Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human,Mouse |
Host species | Rabbit |
Applications | ELISA,IHC-P,IF |
Brand: | Abnova |
Reference: | PAB18171 |
Product name: | ERF polyclonal antibody |
Product description: | Rabbit polyclonal antibody raised against synthetic peptide of ERF. |
Gene id: | 2077 |
Gene name: | ERF |
Gene alias: | PE-2|PE2 |
Gene description: | Ets2 repressor factor |
Immunogen: | A synthetic peptide corresponding to human ERF. |
Protein accession: | P50548 |
Form: | Liquid |
Concentration: | 1 mg/mL |
Recommend dilutions: | Immunohistochemistry (1:50-1:100) Immunofluorescence (1:500-1:1000) ELISA (1:10000) The optimal working dilution should be determined by the end user. |
Storage buffer: | In PBS, 150mM NaCl, pH 7.4 (50% glycerol, 0.02% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Rabbit |
Antigen species / target species: | Human |
Specificity: | This antibody is specific to ERF. |
Reactivity: | Human,Mouse |
Application image: | ![]() |
Application image note: | Immunofluorescence analysis of HeLa cells, using ERF polyclonal antibody (Cat # PAB18171). Peptide "+" means "peptide blocking". |
Applications: | ELISA,IHC-P,IF |
Shipping condition: | Dry Ice |
Publications: | The DNA sequence and biology of human chromosome 19.Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, Hellsten U, Goodstein D, Couronne O, Tran-Gyamfi M, Aerts A, Altherr M, Ashworth L, Bajorek E, Black S, Branscomb E, Caenepeel S, Carrano A, Caoile C, Chan YM, Christensen M, Cleland CA, Copeland A, Dalin E, Dehal P, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Garcia C, Georgescu AM, Glavina T, Gomez M, Gonzales E, Groza M, Hammon N, Hawkins T, Haydu L, Ho I, Huang W, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, La Nature. 2004 Apr 1;428(6982):529-35. |